Resources / Amneal Selects Direct Customer Solutions as 340B Distributor for Select Products

FOR IMMEDIATE RELEASE

Amneal Selects Direct Customer Solutions as 340B Distributor for Select Products

Bells, TN – Direct Customer Solutions (DCS), a leading independent third-party logistics provider specializing in pharmaceutical and direct distribution services, announced today that Amneal Pharmaceuticals has selected DCS as their 340B distributor for select products.

Under this partnership, DCS will deliver a controlled distribution model that supports Amneal’s 340B strategy while ensuring eligible covered entities access to designated products. The collaboration reflects a shared commitment to transparency, program integrity, and operational efficiency within the 340B channel.

DCS will leverage its fully licensed and automated distribution facility, controlled-temperature warehousing, and nationwide shipping capabilities to enhance manufacturer oversight and reduce unnecessary intermediaries.

About Direct Customer Solutions

Founded in 2017 and headquartered in Bells, Tennessee, Direct Customer Solutions is an independent 3PL operating beyond traditional logistics. DCS empowers pharmaceutical manufacturers with greater control, transparency, and optimized operational and financial performance through direct distribution and 340B solutions.

About Amneal

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), headquartered in Bridgewater, New Jersey, is a diversified global biopharmaceutical company focused on expanding access to innovative medicines. The company develops, manufactures, and distributes a broad portfolio of high- quality generic and specialty medicines.